Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» obesity
obesity
Why the obesity drug market is about to get a lot more crowded
Medical Marketing and Media
Fri, 04/26/24 - 11:49 am
obesity
Novo Nordisk
Wegovy
Eli Lilly
Zepbound
Roche
AstraZeneca
Key opinion leaders on GLP-1 receptor agonist clinical trial design
Clinical Trials Arena
Fri, 04/26/24 - 11:41 am
clinical trials
GLP-1 agonist
type 2 diabetes
obesity
Metsera, a well-funded obesity drug startup, sees chance to challenge Lilly, Novo
BioPharma Dive
Thu, 04/18/24 - 11:08 am
Metsera
obesity
funding
US to see surge in new obesity drug launches in next five years
Biopharma Reporter
Tue, 04/16/24 - 10:11 pm
obesity
drug launches
weight loss
European regulators find no evidence of link between new obesity medicines and suicidal thoughts
Stat
Fri, 04/12/24 - 11:09 am
Novo Nordisk
Ozempic
Wegovy
EMA
obesity
weight loss
suicide
Brand managers reflect on historic launch of Wegovy
Medical Marketing and Media
Mon, 04/8/24 - 12:01 pm
Novo Nordisk
Wegovy
obesity
drug launches
brand management
Sanders Blasts Novo Nordisk for ‘Outrageous’ Price of Ozempic, Wegovy
BioSpace
Thu, 03/28/24 - 11:22 am
Novo Nordisk
Bernie Sanders
Ozempic
Wegovy
drug pricing
obesity
diabetes
Ozempic-like drugs linked to low, but increased risk of post-endoscopy pneumonia, study finds
Stat
Thu, 03/28/24 - 11:19 am
Ozempic
obesity
diabetes
Novo Nordisk
aspiration pneumonia
Eli Lilly
Viking touts promising phase I data for weight-loss pill candidate
BioSpace
Tue, 03/26/24 - 11:35 am
Viking Therapeutics
clinical trials
obesity
weight loss
VK2735
Medicare Likely to Negotiate Prices for Obesity Drugs in Next Few Years: CBO
BioSpace
Thu, 03/21/24 - 11:18 am
Novo Nordisk
Wegovy
CBO
obesity
drug pricing
Is Novo Nordisk on the Verge of Another Blockbuster Drug?
Motley Fool
Tue, 03/19/24 - 11:25 am
Novo Nordisk
amycretin
obesity
Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?
Motley Fool
Fri, 03/15/24 - 11:13 am
Pfizer
obesity
M&A
Viking Therapeutics
Regor Initiates Phase 2 Study of Oral Once-daily GLP-1 Agonist RGT-075 for the Treatment of Obesity
Drugs.com
Sun, 03/10/24 - 08:28 pm
Regor Therapeutics
clinical trials
GLP-1 agonist
RGT-075
obesity
Novo Nordisk confident of amycretin obesity drug launch this decade
Reuters
Fri, 03/8/24 - 11:09 am
Novo Nordisk
amycretin
weight loss
obesity
Novo valuation surpasses Tesla on experimental obesity drug data
Reuters
Thu, 03/7/24 - 11:40 am
Novo Nordisk
obesity
weight loss
clinical trials
amycretin
Empros Pharma's Breakthrough: Over 8% Weight Loss in Novel Oral Agent Trial
BNN
Tue, 03/5/24 - 11:51 am
Empros Pharma
obesity
weight loss
clinical trials
Orlistat
acarbose
Americans don't think weight-loss drugs will fix the obesity epidemic
Axios
Wed, 02/28/24 - 10:44 am
obesity
weight loss
Ozempic
Wegovy
Zepbound
GLP-1 agonist
Weight-loss drugs could boost US GDP by 1% in coming years, Goldman says
Reuters
Thu, 02/22/24 - 11:14 pm
obesity
weight loss
GLP-1 agonist
Novo Nordisk
Eli Lilly
Novo Nordisk, Eli Lilly lead industrywide sales surge in Q4
Fierce Pharma
Thu, 02/22/24 - 11:12 pm
earnings
Novo Nordisk
Eli Lilly
obesity
India pharma companies develop versions of Wegovy to get in on weight-loss windfall
Reuters
Thu, 02/22/24 - 11:29 am
India
Wegovy
drug development
obesity
weight loss
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »